End-of-life trajectories of patients with haematological malignancies and advanced solid tumours 87 19. Bruera E, Hui D. Conceptual models for integrating palliative care at cancer centers. J Palliat Med. 2012;15(11):1261-1269. 20. Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ. 2010; 341:c 4863. 21. Grudzen CR, Stone SC, Morrison RS. The palliative care model for emergency department patients with advanced illness. J Palliat Med. 2011;14(8):945-950. 22. Howell DA, Roman E, Cox H, et al. Destined to die in hospital? Systematic review and metaanalysis of place of death in haematological malignancy. BMC Palliat Care. 2010;9:9. 23. Cheng BH, Sham MM, Chan KY, Li CW, Au HY. Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life. Am J Hosp Palliat Care. 2015;3 2(2):2 21-225. 24. Earle CC, Neville BA, LandrumMB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005;17(6):5 05-509. 25. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6): 1133-1138. 26. Verhoef MJ, de Nijs E, Horeweg N, et al. Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study. Support Care Cancer. 2019. 27. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: Where are the methods? Ann Emerg Med. 1996;2 7(3):305-308. 28. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5 (6):649-655. 29. Bruck P, Pierzchlewska M, Kaluzna-Oleksy M, et al. Dying of hematologic patients-- treatment characteristics in a German University Hospital. Support Care Cancer. 2012; 20(11):2895-2902. 30. Goldwasser F, Vinant P, Aubry R, et al. Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registrybased study. Cancer. 2018;124(14):3044-3051. 31. Michael N, Beale G, O’Callaghan C, et al. Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study. BMC Palliat Care. 2019;1 8(1):1 3. 32. Prod’homme C, Jacquemin D, Touzet L, Aubry R, Daneault S, Knoops L. Barriers to endof-life discussions among hematologists: A qualitative study. Palliat Med. 2018;3 2(5):1 0211029. 33. LeBlanc TW, O’Donnell JD, Crowley-Matoka M, et al. Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract. 2015;11(2): e230-238. 34. El-Jawahri A, Keenan T, Abel GA, et al. Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis. Lancet Haematol. 2016;3 (6):e276-283. 35. Manitta VJ, Philip JA, Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med. 2010;13(8):1021-1025. 36. LeBlanc TW, Roeland EJ, El-Jawahri A. Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve? Curr Hematol Malig Rep. 2017;1 2(4):3 00-308. 37. Chung HM, Lyckholm LJ, Smith TJ. Palliative care in BMT. Bone Marrow Transplant. 2009; 43(4):2 65-273. 38. Thomas ML, Crisp N, Campbell K. The importance of quality of life for patients living with myelodysplastic syndromes. Clin J Oncol Nurs. 2012;16 Suppl:47-57. 4
RkJQdWJsaXNoZXIy MTk4NDMw